3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Non-Muscle Invasive Bladder Neoplasms
2
Voice Disorders
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Pleural Diseases
1
Mesothelioma
1
Laryngeal Neoplasms
1
Head and Neck Neoplasms
1
Goiter
1
Esophageal Neoplasms
1
Cystitis, Interstitial
1
Arthralgia
1
Interventions
Gemcitabine
87
Cisplatin
66
Cystectomy
38
pembrolizumab
35
Docetaxel
25
Nivolumab
24
durvalumab
21
Paclitaxel
19
Magnetic Resonance Spectroscopy
18
Radiotherapy
17
Mitomycin
17
Carboplatin
16
atezolizumab
15
Doxorubicin
14
Cystoscopy
14
BCG Vaccine
13
Surveys and Questionnaires
12
Standard of Care
12
avelumab
11
Sunitinib
10
tremelimumab
9
Transurethral Resection of Bladder
9
Ipilimumab
9
Filgrastim
9
Blood Specimen Collection
9
enfortumab vedotin
8
Specimen Handling
8
Neoadjuvant Therapy
8
Methotrexate
8
Methods
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Urinary Bladder Neoplasms
×
Hyaluronic Acid
×
Clear all
NCT07495072
2026-03-27
PRO-GAG
BLAD-HYA Group
Phase NA
Recruiting
56 enrolled